Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $23.3752W HIGH $48.33
Volume
397.51 K
Value Traded
19.08 M
Short % Float
11.52%
-1.95%Week
-11.21%1 Month
+2.46%3 Month
+4.53%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
2.61 B
EPS (TTM)
1.04
P/E Ratio
39.67
Ent. Value
2.52 B
Total Shares
63.34 M
Float Shares
21.07 M
Insiders
66.73%
Institutions
47.02%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
GRDN Catalyst Timeline
Dated clinical, regulatory and corporate events for Guardian Pharmacy Services, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Guardian Pharmacy Services, Inc.
1Total events
0Upcoming
1Tier-1 (high impact)
2026 to 2026Coverage
Event history 1
Past FDA Catalysts and PDUFA Decisions
How GRDN actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Guardian Pharmacy Services, Inc. is not a drug developer. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every GRDN program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Towns DouglasOfficer (See Remarks) | Option | 23,450 113,006 held | $0.00 | 09/27/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in GRDN
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in GRDN for Q2 2026. | ||||
GRDN Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-01-15 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How GRDN ranks across every disease it competes in
Competitive Position is a premium feature
See how GRDN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialGRDN News
-GRDN
Sep 1, 2026Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services, Inc. has successfully acquired the assets of Nautilus Pharmacy, based in Tennessee. This acquisition is expected to enhance Guardian's service offerings and strengthen its market position. The move reflects Guardian's strategy to expand its portfolio and improve its operational capabilities.
Read more →-GRDN
Aug 19, 2026Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services, Inc. will participate in the Jefferies Healthcare Services Conference on September 15, 2026. CEO Fred Burke is scheduled for a fireside chat at 2:25 p.m. CST. The event is open to investors, analysts, and the public via a live audio webcast.
Read more →-GRDN
Aug 6, 2026▲ +11%on this news
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services, Inc. reported its financial results for the second quarter of 2026, showing a revenue increase of 2% year-over-year, totaling $351.8 million. The company served approximately 210,000 residents, marking an 8% growth compared to the previous year. Additionally, Guardian raised its full-year guidance, reflecting a positive outlook.
Read more →-GRDN
Jul 15, 2026Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. has announced the release of its second quarter 2026 financial results, which will occur after market close on August 6, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss these results. Investors can access the call via audio webcast or by phone.
Read more →-GRDN
Jul 1, 2026Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Guardian Pharmacy Services has announced the expansion of its operations in Virginia through the acquisition of Wellness Concepts. This move is part of Guardian's strategy to enhance its service offerings in the region. The acquisition aims to strengthen Guardian's market presence and improve access to pharmacy services for clients in Virginia.
Read more →-GRDN
Jun 23, 2026▼ -6.4%on this newsshared move
Guardian Pharmacy Services Announces Leadership Transitions
Guardian Pharmacy Services, Inc. announced significant leadership transitions as Executive Vice President Kendall Forbes plans to retire on July 1, 2026. David Morris will take over as Chief Operating Officer, while Will Mudd has been appointed Chief Financial Officer. These changes reflect the company's commitment to succession planning and internal talent development.
Read more →-GRDN
Jun 22, 2026▼ -6.4%on this newsshared move
Guardian Pharmacy Services, Inc. Announces Leadership Transitions
Guardian Pharmacy Services, Inc. has announced leadership transitions within the company. The details of these changes were not specified in the article. The announcement indicates a potential shift in company strategy or operations. Further information may be released in the future regarding the new leadership roles.
Read more →-GRDN
Jun 16, 2026Guardian Pharmacy of Jacksonville Promotes Laura Polinsky to President
Guardian Pharmacy of Jacksonville has appointed Laura Polinsky, Pharm.D., as its new president. Polinsky, who has been with the company since 2011, will manage daily operations and foster customer relationships. She succeeds Khristy McClelland, who has moved to a senior vice president role. Polinsky's leadership experience is expected to drive the pharmacy's growth.
Read more →-GRDN
May 12, 2026Guardian Pharmacy Services Announces Senior Leadership Promotions to Support Continued Growth and Operational Alignment
Guardian Pharmacy Services has announced several senior leadership promotions aimed at strengthening operational alignment and supporting growth. Key promotions include new senior vice presidents in various departments and regional leadership roles. The company emphasizes its commitment to local pharmacy leadership to enhance service consistency across its national network.
Read more →-GRDN
May 11, 2026Guardian Pharmacy Services Participates in NatCon 2026 Conference
Guardian Pharmacy Services participated in the NatCon 2026 Conference, a significant event focused on mental health and substance use. Held in Denver, the conference attracted nearly 6,000 professionals and featured over 500 sessions on various topics. Guardian representatives engaged in discussions about improving care delivery in behavioral health, highlighting trends such as the use of artificial intelligence.
Read more →-GRDN
May 8, 2026Andrea Silas Named President of Guardian Pharmacy of Birmingham
Guardian Pharmacy Services has appointed Andrea Silas as the new president of Guardian Pharmacy of Birmingham. Silas, who previously served as the director of account management, will manage daily operations and strategic growth. She succeeds Philip Boyd, who has moved to a vice president role in technology solutions. The pharmacy specializes in LTC services for senior living and skilled nursing communities.
Read more →-GRDN
May 8, 2026Guardian Pharmacy of Minnesota Promotes Jeff Kerr to President of Sauk Rapids Pharmacy
Guardian Pharmacy Services has promoted Jeff Kerr to president of its Sauk Rapids location. Kerr, who has been with the pharmacy since 2015, will oversee daily operations and customer relations, succeeding Mark Boe, who is retiring. His leadership is expected to enhance the pharmacy's growth and maintain its strong reputation.
Read more →-GRDN
May 6, 2026Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance
Guardian Pharmacy Services has released its financial results for the first quarter of 2026 and has updated its guidance for the full year. The report indicates ongoing operations but lacks specific details on financial performance or strategic initiatives. The company aims to provide clearer insights as the year progresses.
Read more →-GRDN
Apr 23, 2026Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference
Guardian Pharmacy Services, Inc. will attend the Bank of America 2026 Healthcare Conference in Las Vegas on May 13, 2026. CEO Fred Burke will participate in a fireside chat at 9:20 a.m. PDT. The event is accessible via a live audio webcast on the company's website, promoting transparency and engagement with stakeholders.
Read more →-GRDN
Apr 15, 2026Guardian Pharmacy Services Names 2025 Pharmacies of the Year
Guardian Pharmacy Services awarded its 2025 Pharmacy of the Year title to two locations: Southern Pharmacy Service's Pink Hill and Guardian Pharmacy of Jacksonville. This marks the first instance of multiple pharmacies receiving the honor simultaneously. The award was presented during the annual Pharmacy Management Meeting in Frisco, Texas, recognizing high performance in key business metrics.
Read more →-GRDN
Apr 14, 2026Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. is set to report its financial results for the first quarter of 2026. The company will also host a conference call to discuss these results with stakeholders. Further details about the financial performance and insights are expected during the call.
Read more →-GRDN
Mar 11, 2026Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance
Guardian Pharmacy Services, a leading provider of long-term care pharmacy services, announced its financial results for the fourth quarter and full year of 2025, showcasing strong growth across revenue and Adjusted EBITDA. The company raised its Adjusted EBITDA guidance for 2026, reflecting positive business momentum and operational efficiencies. Additionally, Guardian expanded its full-service pharmacy count with the acquisition of North Ridge Pharmacy, contributing to an overall increase in service capacity and operational performance. The results indicate a focus on long-term sustainable value for shareholders, despite acknowledging the impact of new drug pricing changes scheduled for 2026.
Read more →-GRDN
Feb 19, 2026Guardian Pharmacy Services Hosts Annual Sales & Account Management Meeting in Atlanta
Guardian Pharmacy Services hosted its annual Sales & Account Management Meeting in Atlanta, gathering nearly 300 employees from over 50 pharmacies. The event aimed to align teams around key priorities for the upcoming year, focusing on best practices and improving customer service. The theme, 'Racing Towards Success,' highlighted the company's commitment to enhancing service delivery.
Read more →-GRDN
Feb 9, 2026Guardian Pharmacy of Orlando Opens Larger Facility to Support Business Growth
Guardian Pharmacy of Orlando has moved to a new 20,000-square-foot facility, more than doubling its previous size. This expansion aims to enhance service delivery to assisted living and healthcare communities in Central Florida. Since its inception in 2017, the pharmacy has grown its staff by 900% and plans to continue hiring through 2026. The new site features modern amenities designed for collaboration and training.
Read more →-GRDN
Jan 21, 2026Guardian Pharmacy Services Expands Western Presence with Montana Acquisition
Guardian Pharmacy Services has acquired North Ridge Pharmacy in Missoula, Montana, marking its first location in the state. This acquisition aims to enhance the company's presence in the western U.S. and meet the increasing demand for long-term care pharmacy services. The pharmacy will continue to operate under its existing leadership, ensuring continuity in service delivery.
Read more →About Guardian Pharmacy Services, Inc.
Headquarters300 GALLERIA PARKWAY SE, ATLANTA, GA, 30339
BIOPHARMAWATCH ELITE PLUS
Trade the next GRDN catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime